PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1362 (116th)

Medical Innovation Never Stops Act of 2019

referredUnited States· United States Congress· EN

Introduced

26 February 2019

Last action

27 February 2019 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Tom Emmer

Subjects

Healthcare

Source updated

7 April 2025

Healthcare

Summary

Medical Innovation Never Stops Act of 2019 This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 26 February 2019

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 26 February 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 26 February 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 27 February 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.